# Single-dose AME Study With [14C]AR882 in Healthy Male Subjects

> **NCT04508426** · PHASE1 · COMPLETED · sponsor: **Arthrosi Therapeutics** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]AR882

## Key facts

- **NCT ID:** NCT04508426
- **Lead sponsor:** Arthrosi Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-16
- **Primary completion:** 2020-08-12
- **Final completion:** 2020-08-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04508426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04508426, "Single-dose AME Study With [14C]AR882 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04508426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*